Skip to content

COOPSTROOM

Active
Cooperative companyfounded 20179 years activeNijverheidsstraat 60A, 8310 Brugge, BelgiumKBO/BCE: BE 0675.918.368
Summary

COOPSTROOM has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €796,306 and a net result of -€410,713. Equity is growing by ~3.9% per year across the filed fiscal years. Its solvency ranks better than 49% of 266 sector peers (NACE 72, fiscal year 2025). The computed 12-month bankruptcy probability is 1.4% (low).

Overview

Activity
Research and development on biotechnology
NACE 72101Other technical testing and analysis NACE 71209
1 site
Size
€1.8mtotal assets 2025
Staff
3.6 FTE
Equity
€796,306
Loss
-€410,713
Turnover not published (abridged schema)
Financial health
63 Healthy Checked score 2025
Bankruptcy probability, 12 months
1.4%
Structure
Parent
Wave after Wave · 100%
Accounts 24 days early3 of 11 deeds read
Why 63- Loss of €410,713, the second in a row (FY 2025)- 1 change of registered office in 24 months+ Size: 3.6 FTE, total assets €1.8m+ Sector Scientific research and development (NACE 72)Show the evidence

Checked score

Score 2025
63 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 26% of its sector peers (NACE 72, micro)
Financial strength · tick = 2024
Weak
Solvency 69-16
equity 44.4% of total assets
Liquidity 50+2
short-term debt 23.3% · cash 7.1%
Profitability 0-4
return on assets -22.9%
Bankruptcy probability, 12 months
1.4% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (936 companies)
Last 24 months 11-2024: 0.5% 12-2024: 0.5%● unchanged vs 11-2024 01-2025: 0.5%● unchanged vs 12-2024 02-2025: 0.5%● unchanged vs 01-2025lowest value 03-2025: 0.5%● unchanged vs 02-2025lowest value 04-2025: 0.6%▲ +0.1 percentage points vs 03-2025 05-2025: 0.6%● unchanged vs 04-2025 06-2025: 0.7%▲ +0.1 percentage points vs 05-2025 07-2025: 0.8%▲ +0.1 percentage points vs 06-2025 08-2025: 1.1%▲ +0.3 percentage points vs 07-2025 09-2025: 1.1%● unchanged vs 08-2025 10-2025: 1.1%● unchanged vs 09-2025 11-2025: 1.1%● unchanged vs 10-2025 12-2025: 3.6%▲ +2.5 percentage points vs 11-2025highest value 01-2026: 1.1%▼ -2.5 percentage points vs 12-2025 02-2026: 1.1%● unchanged vs 01-2026 03-2026: 1.1%● unchanged vs 02-2026 04-2026: 1.2%▲ +0.1 percentage points vs 03-2026 05-2026: 1.2%● unchanged vs 04-2026 06-2026: 1.3%▲ +0.1 percentage points vs 05-2026 07-2026: 1.4%▲ +0.1 percentage points vs 06-2026 08-2026: 1.4%● unchanged vs 07-2026 09-2026: 1.4%● unchanged vs 08-2026 10-2026: 1.4%● unchanged vs 09-2026
Credit up to €50,000 at 30 days acceptable
Liquidity short (current ratio 0.89 against 0.96 in 2024; short-term debt: 23.3% and cash: 7.1% of total assets), and 55.6% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 41% on solvency, 33% on liquidity, 10% on profitability and 21% on growth.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
raises risk · Loss of €410,713, the second in a row (FY 2025)
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian State Gazette
lowers risk · Size: 3.6 FTE, total assets €1.8m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
lowers risk · Sector Scientific research and development (NACE 72)
KBO
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€410,713
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
24 days early
2024
30 days early
2023
60 days early
2022
80 days early
2021
20 days early
2020
71 days early
2019
21 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 44 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 1 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Resignation: Simon Rogissart (director)Declaration
  3. Weakest financial yearnet -€410,713

Key points

  • Risk: 3 loss-making years in a rowloss fiscal year 2025 -€410,713 View
  • Caution: Result fell in 2025from -€242,620 to -€410,713 ▼ 69.3% View
  • Caution: Among the weakest 18% on net resultsector median €1,377 · 265 companies -€410,713 View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Controlled by Wave after Wave 100% View
  • A director leftlatest change 17-03-2026 · 0 in office 1 left View
  • Flemish supportawarded 2022 - 2025 €54,960 View

By topic

Financials

Fiscal year
2025
Total assets
€1.8m
Loss
-€410,713
Solvency
44.4%
Total assets▼ 10.8%
Net result
20182025
Go to Financials

Timeline

Events
16
Since
2019
Next accounts
by 31-07-2027
  1. 23-12-2025Statutes amendment · Miscellaneous
  2. 28-11-2025Resignations: Cedric Depuydt (director) and Pyra Diane…
  3. 01-07-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Cooperative company
Activity
Research and development on biotechnologyNACE 72101
Founded
22-05-2017
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
38
Annual meeting
In June
Purpose
Samenwerken met, deelnemen in, of op gelijk welke wijze, rechtstreeks of onrechtstreeks…
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.